Comprehensive review of targeted therapy for colorectal cancer

YH Xie, YX Chen, JY Fang - Signal transduction and targeted therapy, 2020 - nature.com
Colorectal cancer (CRC) is among the most lethal and prevalent malignancies in the world
and was responsible for nearly 881,000 cancer-related deaths in 2018. Surgery and …

Thyroid cancer, recent advances in diagnosis and therapy

F Nabhan, PH Dedhia… - International journal of …, 2021 - Wiley Online Library
Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

[HTML][HTML] Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

V Subbiah, RJ Kreitman, ZA Wainberg, JY Cho… - Annals of …, 2022 - Elsevier
Background Combined therapy with dabrafenib plus trametinib was approved in several
countries for treatment of BRAF V600E-mutant anaplastic thyroid cancer (ATC) based on an …

Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019

A Maniakas, R Dadu, NL Busaidy, JR Wang… - JAMA …, 2020 - jamanetwork.com
Importance Anaplastic thyroid carcinoma (ATC) historically has a 4-month median overall
survival (OS) from time of diagnosis, with disease-specific mortality approaching 100%. The …

MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas

R Sigaud, TK Albert, C Hess, T Hielscher… - Nature …, 2023 - nature.com
Pediatric low-grade gliomas (pLGG) show heterogeneous responses to MAPK inhibitors
(MAPKi) in clinical trials. Thus, more complex stratification biomarkers are needed to identify …

Sex differences in differentiated thyroid cancer

L Shobab, KD Burman, L Wartofsky - Thyroid, 2022 - liebertpub.com
Background: Sex dimorphism strongly impacts tumor biology, with most cancers having a
male predominance. Uniquely, thyroid cancer (TC) is the only nonreproductive cancer with …

Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose …

H Fu, J Huang, T Zhao, H Wang, Y Chen, W Xu… - Clinical Cancer …, 2023 - AACR
Purpose: Fibroblast activation protein (FAP) is a promising target for tumor treatment. In this
study, we aimed to investigate the safety and efficacy of the albumin binder-conjugated FAP …

[HTML][HTML] Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

J Capdevila, A Awada, D Führer-Sakel… - Cancer Treatment …, 2022 - Elsevier
Most malignant thyroid tumours are initially treated with surgery or a combination of surgery
and radioactive iodine (RAI) therapy. However, in patients with metastatic disease, many …

Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?

M Volante, AK Lam, M Papotti, G Tallini - Endocrine pathology, 2021 - Springer
The molecular characterization of poorly and anaplastic thyroid carcinomas has been
greatly improved in the last years following the advent of high throughput technologies …

Anaplastic thyroid cancer: new horizons and challenges

A Maniakas, M Zafereo… - … and Metabolism Clinics, 2022 - endo.theclinics.com
Anaplastic Thyroid Cancer - Endocrinology and Metabolism Clinics Skip to Main Content
Advertisement Endocrinology and Metabolism Clinics Log in Register Log in Subscribe Claim …